Free Trial

Sapiens International Co. (NASDAQ:SPNS) Shares Purchased by Deutsche Bank AG

Sapiens International logo with Computer and Technology background

Deutsche Bank AG lifted its stake in shares of Sapiens International Co. (NASDAQ:SPNS - Free Report) by 15.4% in the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 67,865 shares of the technology company's stock after purchasing an additional 9,078 shares during the quarter. Deutsche Bank AG owned about 0.12% of Sapiens International worth $1,824,000 at the end of the most recent quarter.

Other large investors have also modified their holdings of the company. Barclays PLC increased its stake in Sapiens International by 415.1% in the 3rd quarter. Barclays PLC now owns 54,640 shares of the technology company's stock valued at $2,036,000 after buying an additional 44,033 shares during the period. Blue Trust Inc. boosted its holdings in shares of Sapiens International by 171.2% in the fourth quarter. Blue Trust Inc. now owns 1,356 shares of the technology company's stock valued at $36,000 after acquiring an additional 856 shares in the last quarter. Y.D. More Investments Ltd increased its stake in shares of Sapiens International by 13.9% during the fourth quarter. Y.D. More Investments Ltd now owns 234,297 shares of the technology company's stock worth $6,338,000 after acquiring an additional 28,512 shares during the period. Principal Financial Group Inc. raised its holdings in Sapiens International by 6.5% during the fourth quarter. Principal Financial Group Inc. now owns 10,400 shares of the technology company's stock worth $279,000 after purchasing an additional 633 shares in the last quarter. Finally, Y Intercept Hong Kong Ltd acquired a new stake in Sapiens International in the fourth quarter valued at about $262,000. Hedge funds and other institutional investors own 30.73% of the company's stock.

Wall Street Analyst Weigh In

Several equities analysts have issued reports on the company. Jefferies Financial Group cut Sapiens International from a "buy" rating to a "hold" rating and dropped their target price for the stock from $36.00 to $28.00 in a research report on Monday, February 3rd. Needham & Company LLC restated a "buy" rating and set a $35.00 target price on shares of Sapiens International in a research report on Wednesday, February 19th. Finally, Barclays increased their price objective on Sapiens International from $28.00 to $31.00 and gave the company an "underweight" rating in a research note on Friday, May 9th. One investment analyst has rated the stock with a sell rating, two have issued a hold rating and three have assigned a buy rating to the company. According to data from MarketBeat, Sapiens International currently has a consensus rating of "Hold" and an average target price of $34.25.

View Our Latest Stock Report on Sapiens International

Sapiens International Trading Up 1.8%

Sapiens International stock traded up $0.50 during trading on Thursday, reaching $28.64. The company had a trading volume of 150,675 shares, compared to its average volume of 155,271. The firm has a market capitalization of $1.60 billion, a price-to-earnings ratio of 22.20 and a beta of 0.95. The company has a debt-to-equity ratio of 0.04, a quick ratio of 2.18 and a current ratio of 2.24. The stock's 50 day moving average price is $27.21 and its two-hundred day moving average price is $27.21. Sapiens International Co. has a 12-month low of $23.69 and a 12-month high of $41.22.

Sapiens International (NASDAQ:SPNS - Get Free Report) last posted its quarterly earnings results on Thursday, May 8th. The technology company reported $0.37 EPS for the quarter, beating the consensus estimate of $0.35 by $0.02. Sapiens International had a net margin of 13.31% and a return on equity of 17.42%. The firm had revenue of $136.11 million for the quarter, compared to analyst estimates of $136.25 million. During the same quarter last year, the firm posted $0.36 earnings per share. Sapiens International's revenue for the quarter was up 1.4% compared to the same quarter last year. As a group, equities analysts expect that Sapiens International Co. will post 1.42 earnings per share for the current fiscal year.

Sapiens International Increases Dividend

The business also recently announced a semi-annual dividend, which was paid on Wednesday, April 16th. Investors of record on Monday, April 7th were issued a dividend of $0.66 per share. This is an increase from Sapiens International's previous semi-annual dividend of $0.22. This represents a dividend yield of 2.2%. The ex-dividend date of this dividend was Monday, April 7th. Sapiens International's dividend payout ratio (DPR) is presently 46.15%.

About Sapiens International

(Free Report)

Sapiens International Corporation N.V. provides software solutions for the insurance industry in North America, the United Kingdom, Europe, the Middle East, Africa, the Asia Pacific, and internationally. The company provides various solutions for property and casualty commercial and personal lines, life and pensions, and reinsurance fields.

Featured Articles

Institutional Ownership by Quarter for Sapiens International (NASDAQ:SPNS)

Should You Invest $1,000 in Sapiens International Right Now?

Before you consider Sapiens International, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Sapiens International wasn't on the list.

While Sapiens International currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

20 Stocks to Sell Now Cover

Today, we are inviting you to take a free peek at our proprietary, exclusive, and up-to-the-minute list of 20 stocks that Wall Street's top analysts hate.

Many of these appear to have good fundamentals and might seem like okay investments, but something is wrong. Analysts smell something seriously rotten about these companies. These are true "Strong Sell" stocks.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Congress Is Pouring Millions Into These 6 Surprising Stocks
3 Dirt-Cheap Stocks in a Market That’s Getting Expensive
Top 3 Defense Stocks to Profit From $175 Billion Golden Dome

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines